Has Suraj Modi received payments from drug or device companies?

Yes. Drug and device makers reported $2,010 in general payments to Suraj Modi across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Suraj Modi did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Suraj Modi come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Suraj Modi

Psychiatry · Longwood, FLNPI 1144756305

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 24.9% of the total. Reporting peaked in 2024 at $1,033 and has fallen 52.0% since, to $496 in 2025.

$2,010in general payments, 2019–2025

Across 101 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$501
Supernus Pharmaceuticals, Inc.$193
Novo Nordisk$182
Corium, LLC$144
Neurocrine Biosciences, Inc.$130
Otsuka America Pharmaceutical, Inc.$100
plus $760 from 21 others

What the payments were for

Food & beverage$1,97098%
Education$412%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	31	$501
Supernus Pharmaceuticals, Inc.	6	$193
Novo Nordisk	10	$182
Corium, LLC	7	$144
Neurocrine Biosciences, Inc.	5	$130
Otsuka America Pharmaceutical, Inc.	6	$100
Takeda Pharmaceuticals U.S.A., Inc.	3	$81
Vanda Pharmaceuticals Inc.	3	$76
Ironshore Pharmaceuticals Inc.	3	$54
Exact Sciences	2	$53
Axsome Therapeutics, Inc.	2	$52
Johnson & Johnson	2	$50
Noven Therapeutics, LLC	2	$48
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$47
E.r. Squibb & Sons, L.L.C.	2	$47
Bayer	2	$37
Lilly USA, LLC	2	$30
Amgen	2	$29
Aimmune Therapeutics, Inc.	1	$24
Collegium Pharmaceutical, Inc.	1	$24
Pfizer	1	$17
Hikma Pharmaceuticals USA	1	$16
Sanofi Pasteur Inc.	1	$15
Daiichi Sankyo Inc.	1	$15
AstraZeneca	1	$15
Almatica Pharma LLC	1	$15
Inspire Medical Systems, Inc.	1	$14

How this compares

$2,010 in reported general payments places this provider in the 70th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydroxyzine Pamoate	12	$149

Paid to pharmacies, not to this prescriber.

Other psychiatry in Longwood

Andrew CutlerLakewood Ranch$5.7M
Richard JacksonBoca Raton$3.6M
Ilan MelnickCoral Gables$2.8M
Todd BroderSt Augustine$1.6M
Heather LuingSaint Augustine$1.5M
Todd GatesWest Melbourne$1.2M
Lawrence ReccoppaGainesville$968K
Thomas ValenteLeesburg$967K
Michelle ScargleClearwater$926K
David SheehanTampa$631K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →